Pawliczak R. Immunotherapy and patient informed consent. Alergologia Polska - Polish Journal of Allergology. 2019;6(1):5-12. doi:10.5114/pja.2019.84260.
APA
Pawliczak, R. (2019). Immunotherapy and patient informed consent. Alergologia Polska - Polish Journal of Allergology, 6(1), 5-12. https://doi.org/10.5114/pja.2019.84260
Chicago
Pawliczak, Rafał. 2019. "Immunotherapy and patient informed consent". Alergologia Polska - Polish Journal of Allergology 6 (1): 5-12. doi:10.5114/pja.2019.84260.
Harvard
Pawliczak, R. (2019). Immunotherapy and patient informed consent. Alergologia Polska - Polish Journal of Allergology, 6(1), pp.5-12. https://doi.org/10.5114/pja.2019.84260
MLA
Pawliczak, Rafał. "Immunotherapy and patient informed consent." Alergologia Polska - Polish Journal of Allergology, vol. 6, no. 1, 2019, pp. 5-12. doi:10.5114/pja.2019.84260.
Vancouver
Pawliczak R. Immunotherapy and patient informed consent. Alergologia Polska - Polish Journal of Allergology. 2019;6(1):5-12. doi:10.5114/pja.2019.84260.
Allergen immunotherapy is a high risk procedure. Therefore, obtaining an informed and written patients informed consent prior the begging is mandatory. The short chapter deals with legal aspect of specific immunotherapy consent. It also delivers examples of the informed consent form (ICF) to be used in an allergist office.
